Actionable news
All posts from Actionable news
Actionable news in ALXN: Alexion Pharmaceuticals, Inc.,

Pre-Market Laggard: Alexion Pharmaceuticals (ALXN)

Trade-Ideas LLC identified Alexion Pharmaceuticals ( ALXN) as a pre-market laggard candidate. In addition to specific proprietary factors, Trade-Ideas identified Alexion Pharmaceuticals as such a stock due to the following factors:

  • ALXN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $168.4 million.
  • ALXN traded 13,341 shares today in the pre-market hours as of 9:20 AM.
  • ALXN is down 4.8% today from yesterday's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ALXN with the Ticky from Trade-Ideas. See the FREE profile for ALXN NOW at Trade-Ideas More details on ALXN: Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. ALXN has a PE ratio of 236. Currently there are 14 analysts that rate Alexion Pharmaceuticals a buy, no analysts rate it a sell, and 5 rate it a hold. The average volume for Alexion Pharmaceuticals has been 1.8 million shares per day over the past 30 days. Alexion has a market cap of $35.6 billion and is part of the health care sector and drugs industry. The stock...